VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $360,076 | +23.5% | 11,130 | +9.4% | 0.01% | 0.0% |
| Q4 2022 | $291,655 | -80.1% | 10,176 | -83.2% | 0.01% | -80.0% |
| Q3 2022 | $1,465,000 | -66.2% | 60,744 | -61.6% | 0.04% | -69.5% |
| Q2 2022 | $4,329,000 | +626.3% | 158,092 | +917.1% | 0.13% | +835.7% |
| Q1 2022 | $596,000 | +51.7% | 15,544 | +26.6% | 0.01% | +55.6% |
| Q4 2021 | $393,000 | -38.2% | 12,279 | -43.0% | 0.01% | -47.1% |
| Q3 2021 | $636,000 | -46.7% | 21,560 | -38.7% | 0.02% | -51.4% |
| Q2 2021 | $1,194,000 | +22.5% | 35,146 | +41.1% | 0.04% | -32.7% |
| Q3 2020 | $975,000 | +69.0% | 24,900 | +58.4% | 0.05% | +40.5% |
| Q2 2020 | $577,000 | +36.7% | 15,724 | +9.2% | 0.04% | 0.0% |
| Q4 2019 | $422,000 | – | 14,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |